Carlsbad, United States
PrecisionMed is a biotechnology company based in the United States. Established in 1996, the company's slogan "Fueling Innovation and Improving Lives" encapsulates its core mission. PrecisionMed specializes in providing essential products and services that drive advancements in genetics, drug discovery, biomarker research, and molecular diagnostics.
The company serves as a primary supplier of meticulously annotated human biological materials and boasts the distinction of being the largest private global source of longitudinally collected Human Cerebrospinal Fluid from both healthy and diseased populations. Their extensive clientele comprises numerous major pharmaceutical and biotechnology firms, alongside various academic and government research institutions.
PrecisionMed's focus in the United States revolves around the prospective longitudinal collection of blood products and cerebrospinal fluid, coupled with comprehensive, relevant clinical data. Notably, all samples are obtained under U.S. IRB-approved clinical protocols, covering a wide array of therapeutic and diagnostic domains. The acquisition and curation of samples and data are facilitated through PrecisionMed's developed networks, comprising specialized physician clinical sites with significant research experience.
As of now, there is no available information regarding their last investment or the investors involved in the latest funding round.
